Grants & Programs

From Milestones to Medicines: Translating Tumor Immunology Research into Immunotherapies

October 01, 2012
09:30 AM
Millennium Conference Center, New York, NY

“From Milestones to Medicines: Translating Tumor Immunology Research into Immunotherapies,” held October 1-3, 2012, at the Millennium Conference Center in New York City, featured three days of plenary lectures by the world’s leading immunologists. Approximately 360 students, postdoctoral fellows, and investigators from more than 70 academic institutions and biopharmaceutical companies attended the 20th Annual International Cancer Immunotherapy Symposium, which was dedicated to Dr. Lloyd J. Old, under whose leadership the series was founded. The meeting also included a poster session with presentations by nearly 130 scientists, six of which were invited to deliver a lecture during the general session.

Download Final Program (PDF)


  • Paolo A. Ascierto, Istituto Nazionale Tumori Fondazione “G. Pascale”
  • Patrick A. Baeuerle, Amgen Research (Munich) GmbH 
  • Gregory L. Beatty, Hospital of the University of Pennsylvania
  • Ana Carrizosa Anderson, Brigham & Women’s Hospital and Harvard Medical School
  • Padmanee Sharma, University of Texas MD Anderson Cancer Center
  • Andrew Weinberg, Providence Cancer Center


  • Julie Magarian Blander, The Tisch Cancer Institute, Mount Sinai School of Medicine
  • Philippa C. Marrack, National Jewish Health
  • Jedd D. Wolchok, Memorial Sloan-Kettering Cancer Center


  • James P. Allison, Ludwig Center for Cancer Immunotherapy, MSKCC
  • Ugur Sahin, TRON
  • Robert D. Schreiber, Washington University School of Medicine
  • Pramod K. Srivastava, Carole and Ray Neag Comprehensive Cancer Center, University of Connecticut School of Medicine

Immune Modulation by Stroma

  • Ellen Puré, The Wistar Institute
  • Thomas F. Gajewski, University of Chicago
  • Vincenzo Bronte, University Hospital Verona
  • Douglas T. Fearon, CRUK Cambridge Research Institute and Cambridge University  School of Clinical Medicine
  • Giorgio Trinchieri, Center for Cancer Research, National Cancer Institute, NIH
  • Benoît J. Van den Eynde, Ludwig Institute for Cancer Research, Brussels Branch,  de Duve Institute Université catholique de Louvain

Other Topics that Impact Immunity

  • Pramod K. Srivastava, University of Connecticut School of Medicine
  • Mitchell Kronenberg, La Jolla Institute for Allergy & Immunology
  • Alexander Rudensky, Memorial Sloan-Kettering Cancer Center
  • George C. Prendergast, Lankenau Institute for Medical Research

Emerging Technologies

  • Kunle Odunsi, Roswell Park Cancer Institute
  • Jérôme Galon, Inserm U872, Cordeliers Research Center
  • Peter Friedl, Radboud University Nijmegen Medical Centre, and
  • Scott Tanner, University of Toronto, and DVS Sciences Inc.

Highlights from the Abstracts

  • Jacalyn Rosenblatt, Beth Israel Deaconess Medical Center
  • Daniel Hirschhorn-Cymerman, Memorial Sloan-Kettering Cancer Center
  • Tangsheng Yi, University of California, San Francisco, CA
  • Magnus von Knebel Doeberitz, University Hospital Heidelberg
  • Maud Condomines, Memorial Sloan-Kettering Cancer Center
  • Julia Templin, University Medical Center Hamburg-Eppendorf